India's Weight-Loss Drug Misuse for Weddings
Analysis based on 8 articles · First reported Apr 03, 2026 · Last updated Apr 03, 2026
The misuse of weight-loss drugs like Eli Lilly and Company===Tirzepatide and Novo Nordisk===Semaglutide in India for cosmetic purposes, coupled with the entry of cheaper generics, is creating a complex market dynamic. While sales for Eli Lilly and Company and Novo Nordisk are increasing, regulatory scrutiny in India is intensifying, potentially leading to stricter controls and impacting future market growth and profitability for pharmaceutical companies.
In India, there's a growing trend of soon-to-be brides and grooms using weight-loss drugs like Eli Lilly and Company's Eli Lilly and Company===Tirzepatide and Novo Nordisk's Novo Nordisk===Semaglutide and Novo Nordisk===Semaglutide for cosmetic purposes before weddings, driven by societal pressures. Wellness clinics, such as Klarity Skin Clinic, are promoting 'pre-wedding' packages that include these injections. Doctors like Rajat Goel and Swati Pradhan express concern, emphasizing that these drugs are for medical indications, not quick cosmetic fixes. The Indian drug regulator is intensifying scrutiny due to unauthorized sales and promotion, especially as local drugmakers begin selling cheaper generic versions of semaglutide after patent expiration. This situation highlights a significant public health concern regarding drug misuse and potential regulatory actions that could affect the pharmaceutical market in India.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard